Experts: FDA layoffs will slow device reviews, impact decision making
Regulatory NewsJoanne S. Eglovitch
Approval/marketing authorizationAudit/inspectionCDRHEnforcementLeadershipMDUFAMedical DevicesPostmarketing requirement/postmarketing commitmentPremarket approval (PMA)Product developmentProject managementRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)